Brief: Bausch Can Block Alvogen From Copying Xifaxan Diarrhea Drug Until 2029-Us Appeals Court
11/04/2024 16:48
April 11 (Reuters) - Bausch Health Companies Inc
BHC.TO :
* BAUSCH CAN BLOCK ALVOGEN FROM COPYING XIFAXAN DIARRHEA
DRUG
UNTIL 2029-US APPEALS COURT
Further company coverage: BHC.TO
(Reporting By Caroline Humer)
((caroline.humer@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data